The stock has been in a pronounced downtrend over the observed period, with the price falling from $56.23 in early October 2025 to $45.30 by March 31, 2026. This represents a significant decline, culminating in a 1-month drop of 12.62% and a 3-month decline of 9.42%, both underperforming the broader market as indicated by negative relative strength figures. Short-term performance has been weak, with the stock down 12.62% over the past month and 9.42% over the past three months. This contrasts with the S&P 500's declines of 5.25% and 4.63% over the same periods, highlighting TSCO's significant underperformance with relative strength readings of -7.37 and -4.79, respectively. The current price of $45.30 is near the lower end of its 52-week range of $44.44 to $63.99, sitting just 1.9% above the 52-week low. This positioning indicates the stock is in a technically oversold zone, though no RSI data was provided to confirm this condition.

Revenue growth has been modest but positive, with the most recent quarterly revenue of $3.90 billion showing a year-over-year growth of 3.31%. Profitability has been stable, with the quarterly net margin reported at 5.83%, though this represents a sequential decline from the higher margins seen in Q2 and Q3 of 2025. The company's financial health shows a high degree of leverage, with a debt-to-equity ratio of 2.30. However, it maintains adequate liquidity with a current ratio of 1.34. Cash flow generation is solid, with trailing twelve-month free cash flow of $740.5 million. Operational efficiency remains a key strength, as evidenced by a high return on equity of 42.46% and a return on assets of 8.84%. These metrics indicate effective use of shareholder capital and company assets to generate profits.